Delivery Order SPE2DB24D1205-SPE2DB25FCTUQ

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,531.42 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VYVANSE 60 MG CAPSULE 100S. The $1,301.37 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,897.85 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract covers the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. The overall DLA Troop Support Medical IDC held by Amerisourcebergen is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,760.52 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.37 firm fixed price delivery order is for the supply of 4566777755 units of 30 mg VYVANSE capsules. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.78 firm fixed-price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S to support federal healthcare programs. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,110.55 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,417.98, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract covers the supply of VYVANSE 60 MG CAPSULE 100S, a specialty medication, to support military healthcare programs. The contract has no set-aside designation, indicating open...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,259.32, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTUQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,635.68 for the supply of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a comprehensive $999,999,999 contract that provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has also secured a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/9/25, 9:54 AM